Hamann, Till
Lemke, Stella
Kropp, Peter
Rimmele, Florian
Jürgens, Tim P.
Frielitz, Fabian
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 19 February 2021
Accepted: 14 July 2021
First Online: 24 July 2021
Declarations
:
: All methods were carried out by following relevant guidelines and regulations.The regional Ethics Committee of the University of Rostock approved this study (No. A 2017–0186).Informed consent was obtained from all subjects.
: All authors consent to publish the results.
: T. Hamann declares that there is no conflict of interests.S. Lemke declares that there is no conflict of interests.P. Kropp declares that he has received honoraria for training events and advisory councils from Novartis, Lilly, and Teva.F. Rimmele declares that he has received honoraria for lecturing or advisory boards and / or convention support from Novartis and Pharm Allergan.T. Jürgens declares that he has received honoraria for lectures or advisory boards from Allergan, Hormosan, Lilly, Novartis. Sanofi-Aventis and Teva.F. Frielitz declares that there is no conflict of interests.